Skip Nav Destination
Issues
Editorial
Review
Featured Articles
Clinical Trials
Vaccination with Autologous Tumor-derived Heat-Shock Protein Gp96 after Liver Resection for Metastatic Colorectal Cancer1
Vincenzo Mazzaferro; Jorgelina Coppa; Matteo G. Carrabba; Licia Rivoltini; Marcello Schiavo; Enrico Regalia; Luigi Mariani; Tiziana Camerini; Alfonso Marchianò; Salvatore Andreola; Roberto Camerini; Marco Corsi; Jonathan J. Lewis; Pramod K. Srivastava; Giorgio Parmiani
Molecular Oncology, Markers, Clinical Correlates
Experimental Therapeutics, Preclinical Pharmacology
Melanoma Differentiation-associated 7 (Interleukin 24) Inhibits Growth and Enhances Radiosensitivity of Glioma Cells in Vitro and in Vivo1
Adly Yacoub; Clint Mitchell; Andrea Lister; Irina V. Lebedeva; Devanand Sarkar; Zao-Zhong Su; Carter Sigmon; Robert McKinstry; Viswanathan Ramakrishnan; Liang Qiao; William C. Broaddus; Rahul V. Gopalkrishnan; Steven Grant; Paul B. Fisher; Paul Dent
Regular Articles
Clinical Trials
Phase I Study of Low-Dose Suramin as a Chemosensitizer in Patients with Advanced Non-Small Cell Lung Cancer1
Miguel A. Villalona-Calero; M. Guillaume Wientjes; Gregory A. Otterson; Steven Kanter; Donn Young; Anthony J. Murgo; Beth Fischer; Carrie DeHoff; Danny Chen; Teng-Kuang Yeh; SaeHeum Song; Michael Grever; Jessie L-S. Au
Molecular Oncolgy, Markers, Clinical Correlates
Molecolar Oncology, Markers, Clinical Correlates
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Association of KIT Exon 9 Mutations with Nongastric Primary Site and Aggressive Behavior: KIT Mutation Analysis and Clinical Correlates of 120 Gastrointestinal Stromal Tumors1
Cristina R. Antonescu; Gunhild Sommer; Lisa Sarran; Sylvia J. Tschernyavsky; Elyn Riedel; James M. Woodruff; Mark Robson; Robert Maki; Murray F. Brennan; Marc Ladanyi; Ronald P. DeMatteo; Peter Besmer
Development of a Real-Time Polymerase Chain Reaction Assay for Prediction of the Uptake of Meta-[131I]iodobenzylguanidine by Neuroblastoma Tumors1
Sean Carlin; Rob J. Mairs; Anthony G. McCluskey; Deborah A. Tweddle; Alan Sprigg; Christine Estlin; Julian Board; Rani E. George; Caroline Ellershaw; Andrew D. J. Pearson; John Lunec; Paolo G. Montaldo; Mirco Ponzoni; Berthe L. van Eck-Smit; Cees A. Hoefnagel; Marieke D. van den Brug; Godelieve A. M. Tytgat; Huib N. Caron
Disparity of Sensitivities in Detection of Radiation-Naïve and Postirradiation Recurrent Nasopharyngeal Carcinoma of the Undifferentiated Type by Quantitative Analysis of Circulating Epstein-Barr Virus DNA1,2
Sing-fai Leung; Y. M. Dennis Lo; Anthony T. C. Chan; Kai-fai To; Edward To; Lisa Y. S. Chan; Benny Zee; Dolly P. Huang; Philip J. Johnson
Experimental Therapeutics, Preclinical Pharmacology
Preclinical Characterization of CG53135 (FGF-20) in Radiation and Concomitant Chemotherapy/Radiation-induced Oral Mucositis
Enrique Alvarez; Edward G. Fey; Pascal Valax; Zachary Yim; Jeffrey D. Peterson; Medhi Mesri; Michael Jeffers; Matthew Dindinger; Nancy Twomlow; Ashwini Ghatpande; William J. LaRochelle; Stephen T. Sonis; Henri S. Lichenstein
Tuberous Sclerosis-associated Neoplasms Express Activated p42/44 Mitogen-activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth1
Baskaran Govindarajan; Melissa C. Mizesko; Mark Steven Miller; Hiroaki Onda; Matthew Nunnelly; Katherine Casper; Daniel Brat; Cynthia Cohen; Jack L Arbiser
The Combination of the Tyrosine Kinase Receptor Inhibitor SU6668 with Paclitaxel Affects Ascites Formation and Tumor Spread in Ovarian Carcinoma Xenografts Growing Orthotopically1
Angela Garofalo; Elitza Naumova; Luigi Manenti; Carmen Ghilardi; Gabriele Ghisleni; Mario Caniatti; Tina Colombo; Julie M. Cherrington; Eugenio Scanziani; Maria Ines Nicoletti; Raffaella Giavazzi
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.